Research and Development

Showing 15 posts of 9612 posts found.

Daiichi Sankyo researchers

Daiichi Sankyo to expand access to clinical trial data

February 3, 2016 Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …
Brandicourt

Sanofi plans R&D jobs cuts in France

February 3, 2016 Manufacturing and Production, Research and Development Sanofi, Teva, cuts, job losses, olivier brandicourt, redundancies

Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …

Pfizer revenues down, but above expectations

February 3, 2016 Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
dr_barbara_fleck_-_head_of_ip-web

Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property

February 2, 2016 Research and Development Crescendo Biologics

Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …

Porton Biopharma expands cancer drug manufacturing capacity

February 2, 2016 Manufacturing and Production, Research and Development Erwinase

UK Life Sciences Minister George Freeman yesterday opened a new multi-million pound pharmaceutical manufacturing facility at Wiltshire-based Porton Biopharma Limited …
sun_pharma_logo

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
sanofi

Sanofi Pasteur launches Zika vaccine R&D

February 2, 2016 Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus

Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …
bms_logo_square

Europe approves BMS hep C drug for HIV and liver transplant patients

February 1, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza

The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …
merck_innovation_centre

Merck launches health tech start-up program in Africa

February 1, 2016 Manufacturing and Production, Medical Communications, Research and Development

Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …
Westminster

Ministers reject bid to revive Off Patent Drugs Bill

February 1, 2016 Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs

Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …
allergan

Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016 Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …
clinical trial patient

FDA plans greater diversity in clinical trials

January 29, 2016 Medical Communications, Research and Development FDA, Robert Califf, clinical trial, patient recruitment

The FDA is to focus on increasing patient diversity in clinical trials in 2016, to “ensure that research participants are …

Aslan Pharmaceuticals appoints eminent cancer researcher to chair scientific advisory board

January 28, 2016 Research and Development Aslan, Professor Sir David Lane

Aslan Pharmaceuticals has appointed four global cancer experts to its new scientific advisory board.The Board will be chaired by the …
opdivo

BMS says Phase III Opdivo head and neck cancer trial stopped early

January 28, 2016 Medical Communications, Research and Development

Bristol Myers Squibb has announced a Phase III study of Opdivo (nivolumab) in head and neck cancer patients was stopped early …
Brain scan

Lilly and Roche team up on new Alzheimer’s diagnostic test

January 28, 2016 Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly

Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …
The Gateway to Local Adoption Series

Latest content